EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer

Eric R Reed, Stacy A Jankowski, Anthony J Spinella, Vikki Noonan, Robert Haddad, Kenichi Nomoto, Junji Matsui, Manish V Bais, Xaralabos Varelas, Maria A Kukuruzinska, Stefano Monti

Translational Research · 2023

DOI: 10.1016/j.trsl.2023.05.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2023. Verfasst von Eric R Reed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Data Intensive Studies Center, Tufts University, Medford, Massachusetts; Section of Computational Biomedicine, Boston University Chobanian & Avedisia…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, National Institutes of Health, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancers, which include oral squamous cell carcinoma (OSCC) as a major subsite, exhibit cellular plasticity that includes features of an epithelial-mesenchymal transition (EMT), referred to as partial-EMT (p-EMT). To identify molecular mechanisms contributing to OSCC plasticity, we performed a multiphase analysis of single cell RNA sequencing (scRNAseq) data from human OSCC. This included a multiresolution characterization of cancer cell subgroups to identify pathways and cell states that are heterogeneously represented, followed by casual inference analysis to elucidate activating and inhibitory relationships between these pathways and cell states. This approach revealed signaling networks associated with hierarchical cell state transitions, which notably included an association between β-catenin-driven CREB-binding protein (CBP) activity and mTORC1 signaling. This network was associated with subpopulations of cancer cells that were enriched for markers of the p-EMT state and poor patient survival. Functional analyses revealed that β-catenin/CBP induced mTORC1 activity in part through the transcriptional regulation of a raptor-interacting protein, chaperonin containing TCP1 subunit 5 (CCT5). Inhibition of β-catenin-CBP activity through the use of the orally active small molecule, E7386, reduced the expression of CCT5 and mTORC1 activity in vitro, and inhibited p-EMT-associated markers and tumor development in a murine model of OSCC. Our study highlights the use of multiresolution network analyses of scRNAseq data to identify targetable signals for therapeutic benefit, thus defining an underappreciated association between β-catenin/CBP and mTORC1 signaling in head and neck cancer plasticity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsAnimalsHumansMicebeta CateninCell Line, TumorCell MovementCREB-Binding ProteinEpithelial-Mesenchymal TransitionSquamous Cell Carcinoma of Head and NeckWnt Signaling PathwayPeptide FragmentsSialoglycoproteins

Stichwörter der Autor:innen

Head and neck cancerSingle cell RNA sequencingepithelial-mesenchymal transitionmTORC1β-catenin

Substanzen

beta CateninCREB-Binding ProteinCTNNB1 protein, humanbone sialoprotein (35-62), humanPeptide FragmentsSialoglycoproteins

Autor:innen und Institutionen

  • Data Intensive Studies Center, Tufts University, Medford, Massachusetts; Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts; Bioinformatics Program, B…
  • Department of Translational Dental Medicine, Boston University School of Dental Medicine, Boston, Massachusetts; Molecular and Translational Medicine Program, Boston University School of Medicine, Boston, Massachusetts.
  • Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts.
  • Division of Oral Pathology, Boston University School of Dental Medicine, Boston, Massachusetts.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Eisai Inc, 200 Metro Blvd, Nutley, NJ, 07110, USA.

Förderung

  • NIDCR NIH HHS
  • National Institutes of Health
  • American Cancer Society
  • NIDCR
  • Eisai Incorporated

Zitieren

APA

Reed, E. R., Jankowski, S. A., Spinella, A. J., Noonan, V., Haddad, R., Nomoto, K., Matsui, J., Bais, M. V., Varelas, X., Kukuruzinska, M. A., & Monti, S. (2023). β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer. Translational Research. https://doi.org/10.1016/j.trsl.2023.05.007

Vancouver

Reed ER, Jankowski SA, Spinella AJ, Noonan V, Haddad R, Nomoto K, et al. β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer. Translational Research. 2023. doi:10.1016/j.trsl.2023.05.007

BibTeX
@article{Reed2023,
  author = {Reed, Eric R and Jankowski, Stacy A and Spinella, Anthony J and Noonan, Vikki and Haddad, Robert and Nomoto, Kenichi and Matsui, Junji and Bais, Manish V and Varelas, Xaralabos and Kukuruzinska, Maria A and Monti, Stefano},
  title = {β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer},
  journal = {Translational Research},
  year = {2023},
  doi = {10.1016/j.trsl.2023.05.007}
}
Kostenlos starten →